Management of the Top 10 Most Common Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy
Bryan J. Schneider, Christina Lacchetti, Kathryn Bollin
Topics & Concepts
MedicineAdverse effectInternal medicineImmune systemImmunotherapyOncologyPembrolizumabNivolumabClinical trialProgrammed cell death 1DiscontinuationIpilimumabMEDLINEIntensive care medicineImmunologyDiseaseImmune checkpointAntibody therapyCancer Immunotherapy and BiomarkersChronic Lymphocytic Leukemia ResearchNeuroendocrine Tumor Research Advances